Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-22 Gray Nancy Ryan Director Grant or award · Non-Qualified Stock Option (right to buy) +3,050 3,050
2022-12-22 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) +6,623 6,623
2022-12-22 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +4,484 4,484
2022-12-22 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +4,484 4,484
2022-12-22 Davis Todd C Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +2,081 2,081
2022-12-22 Espinoza Octavio Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +6,620 6,620
2022-12-16 HIGGINS JOHN L Director Sale −10,000 $61.87 $619K 422,984
2022-12-13 Korenberg Matthew E President & COO Grant or award +14,000 96,428
2022-12-13 Korenberg Matthew E President & COO Grant or award · Employee Stock Option (right to buy) +30,000 30,000
2022-12-13 Espinoza Octavio Chief Financial Officer Grant or award +11,000 18,670
2022-12-13 Espinoza Octavio Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +20,000 20,000
2022-12-12 HIGGINS JOHN L Director Option exercise +20,000 $12.78 $256K 436,928
2022-12-12 HIGGINS JOHN L Director Returned to the company −3,944 $64.80 $256K 432,984
2022-12-12 HIGGINS JOHN L Director Option exercise · Non-Qualified Stock Option (right to buy) −20,000 20,335
2022-12-05 Davis Todd C Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +132,000 132,000
2022-11-30 Korenberg Matthew E President & COO Shares withheld for taxes −3,593 $72.90 $262K 82,428
2022-11-30 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −9,803 $72.90 $715K 416,928
2022-11-30 Espinoza Octavio Chief Financial Officer Shares withheld for taxes −1,187 $72.90 $87K 7,670
2022-11-30 Reardon Andrew See Remarks Shares withheld for taxes −1,073 $72.90 $78K 10,940
2022-11-18 HIGGINS JOHN L Chief Executive Officer Option exercise +10,000 $12.78 $128K 426,731

Page 27 of 43 · 858 trades